NEW YORK – Foundation Medicine announced Friday its collaboration with Takeda Pharmaceuticals USA to develop Foundation's companion diagnostics for use with Takeda's lung cancer portfolio.
Financial and other terms of the deal were not disclosed.
NEW YORK – Foundation Medicine announced Friday its collaboration with Takeda Pharmaceuticals USA to develop Foundation's companion diagnostics for use with Takeda's lung cancer portfolio.
Financial and other terms of the deal were not disclosed.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.